Concepedia

Sarah Mosier

SM

Statistics

Publications

10

Citations

820

H-Index

10

Active since

1993

Affiliations

Scynexis (United States)(Current)

Southern Research Institute

La Roche College

Scripps Research Institute

Sarah Mosier is an author at Scynexis (United States) specializing in molecular virology, life sciences, and infectious diseases.

Publications per year

1993–2012

10

Publications

10

Emergence and Evolution of Enfuvirtide Resistance following Long-Term Therapy Involves Heptad Repeat 2 Mutations within gp41

Li Xu, Anton Pozniak, Adrian Wildfire et al. · Antimicrobial Agents and Chemotherapy · 2005 · 168 citations · Full text

, , +17

Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates

Prakash Sista, Tom Melby, Donna K. Davison et al. · AIDS · 2004 · 154 citations

, , +17

Impact of Human Immunodeficiency Virus Type 1 gp41 Amino Acid Substitutions Selected during Enfuvirtide Treatment on gp41 Binding and Antiviral Potency of Enfuvirtide In Vitro

Mike Mink, Sarah Mosier, S. Janumpalli et al. · Journal of Virology · 2005 · 129 citations · Full text

, , +17

Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection.

Barbara Rehermann, C Pasquinelli, Sarah Mosier et al. · Journal of Clinical Investigation · 1995 · 121 citations · Full text

, , +17

The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection

Sam Hopkins, Betty DiMassimo, Pamela Rusnak et al. · Journal of Hepatology · 2012 · 92 citations

, , +14

1–5 of 10